Isolated Hypogonadotropic HypogonadismSymptoms, Doctors, Treatments, Advances & More
Learn About Isolated Hypogonadotropic Hypogonadism
Baylor Medicine At McNair - Urology
Mohit Khera, M.D., M.B.A., M.P.H., Associate Professor, is the Director of the Laboratory for Andrology Research at McNair Medical Institute, Baylor College of Medicine. He is also the Medical Director of the Executive Health Program at Baylor. Dr. Khera is a Board-certified urologist specializing in male infertility, male and female sexual dysfunction, and declining testosterone levels in aging men. Dr. Khera's research focuses on the efficacy of botulinum toxin type A in treating Peyronie's disease as well as genetic and epigenetic studies on post-finasteride syndrome patients and testosterone replacement therapy. Dr. Khera is rated as an Elite provider by MediFind in the treatment of Isolated Hypogonadotropic Hypogonadism. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Hypogonadism, Peyronie Disease, Erectile Dysfunction (ED), Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Khera is currently accepting new patients.
Massachusetts General Hospital
Stephanie Seminara is an Endocrinologist practicing medicine in Boston, Massachusetts. Dr. Seminara is rated as an Elite provider by MediFind in the treatment of Isolated Hypogonadotropic Hypogonadism. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Hypogonadotropic Hypogonadism, Hypogonadism, Isolated Hypogonadotropic Hypogonadism, Kallmann Syndrome, and Hormone Replacement Therapy (HRT).
Penn Endocrinology Perelman
Peter Snyder is an Endocrinologist practicing medicine in Philadelphia, Pennsylvania. Dr. Snyder is rated as an Elite provider by MediFind in the treatment of Isolated Hypogonadotropic Hypogonadism. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Isolated Hypogonadotropic Hypogonadism, Hypogonadism, Hypogonadotropic Hypogonadism, Pituitary Tumor, and Hormone Replacement Therapy (HRT). Dr. Snyder is currently accepting new patients.
Summary: The aim of this trial is to evaluate whether testosterone replacement results in greater improvement in pain perception, pain tolerance, sexual function, fatigue, and quality of life when compared with placebo in men with chronic spinal pain treated with opioids who have opioid-induced hypogonadism (low testosterone).
Background: \- During puberty, children begin to develop into adults. Problems with the hormones released during puberty can affect the reproductive system. Some people have low hormone levels that severely delay or prevent puberty. Others start puberty abnormally early. Other people may have a normal puberty but develop reproductive disorders later in life. Researchers want to study people with reproductive ...